SYNAGEVA BIOPHARMA CORP's ticker is GEVA and the CUSIP is 87159A103. A total of 84 filers reported holding SYNAGEVA BIOPHARMA CORP in Q4 2013. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $59,563,000 | +10.5% | 610,716 | +5.1% | 0.01% | 0.0% |
| Q4 2014 | $53,909,000 | +32.1% | 580,981 | -2.1% | 0.01% | +28.6% |
| Q3 2014 | $40,801,000 | -34.0% | 593,209 | +0.5% | 0.01% | -30.0% |
| Q2 2014 | $61,845,000 | +28.0% | 590,125 | +1.3% | 0.01% | +25.0% |
| Q1 2014 | $48,314,000 | +36.0% | 582,309 | +6.1% | 0.01% | +33.3% |
| Q4 2013 | $35,518,000 | +33.8% | 548,793 | +31.1% | 0.01% | +20.0% |
| Q3 2013 | $26,537,000 | +60.2% | 418,616 | +6.1% | 0.01% | +66.7% |
| Q2 2013 | $16,565,000 | – | 394,585 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|